<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=arrhythmicdrugs&amp;format=rss"><channel><title>arrhythmicdrugs - BingNews</title><link>http://www.bing.com/news/search?q=arrhythmicdrugs&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>arrhythmicdrugs</title><link>http://www.bing.com/news/search?q=arrhythmicdrugs&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Anti-arrhythmic Drugs Linked to Bradycardia in Patients With AF</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a07819852da4d5a9761585a5c9caa10&amp;url=https%3a%2f%2fwww.medscape.com%2fviewarticle%2fanti-arrhythmic-drugs-linked-bradycardia-patients-af-2024a10004vw&amp;c=13673862429782259125&amp;mkt=en-us</link><description>A new study has highlighted the risks for syncope and bradycardia as potential side effects with anti-arrhythmic drugs when used for the treatment of atrial fibrillation (AF). Researchers analyzed ...</description><pubDate>Thu, 14 Mar 2024 17:00:00 GMT</pubDate><News:Source>Medscape</News:Source></item><item><title>Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a07819852da4d5a9761585a5c9caa10&amp;url=https%3a%2f%2fwww.nature.com%2farticles%2fncomms1351&amp;c=2016604442066577034&amp;mkt=en-us</link><description>Cardiac sodium channels are established therapeutic targets for the management of inherited and acquired arrhythmias by class I anti-arrhythmic drugs (AADs). These drugs share a common target receptor ...</description><pubDate>Mon, 13 Jun 2011 17:00:00 GMT</pubDate><News:Source>Nature</News:Source></item></channel></rss>